References

The prevalence of 78 autoimmune diseases in Catalonia (MASCAT‐PADRIS Big Data Project)

10.1016/j.autrev.2019.102448 · 2020 · External reference

2023 International Rome consensus for the nomenclature of Sjögren disease

10.1038/s41584-025-01268-z · 2025 · External reference

Early diagnosis and treatment for Sjögren's syndrome: current challenges, redefined disease stages and future prospects

10.1016/j.jaut.2020.102590 · 2021 · External reference

Sjögren syndrome

10.1038/nrdp.2016.47 · 2016 · External reference

Praparate zu dem Vortag über Entstehung der Netzhautablosung und über verscheiedene Hornhautaffektionen

1882 · External reference

On “dry mouth”, or suppression of the salivary and buccal secretions

1888 · External reference

“Xerostomia”—a term suggested for the affection known as dry mouth

10.1016/s0140-6736(00)30178-7 · 1889 · External reference

Unresolved reference

1892 · External reference

Insuffisance progressive et atrophie des glandes salivaires et muqueuses de la bouche, des conjonctives (et parfois des muqueuses nasale, laryngée, vulvaire), sécheresse de la bouche, des conjonctives, etc

1926 · External reference

IV. Diseases of cornea: keratitis filamentosa and chronic arthritis

1927 · External reference

Zur kenntnis der keratoconjunctivitis sicca (keratitis filiformis bei hypofunktion der Tranendrüsen)

1933 · External reference

Zur kenntnis der keratoconjunctivitis sicca II: allgemeine Symptomatologie und Ätiologie

10.1111/j.1755-3768.1935.tb04186.x · 1935 · External reference

Zur kenntnis der keratoconjunctivitis sicca III: mikroskopische Veränderungen der Nasendrüsen

10.1111/j.1755-3768.1935.tb04187.x · 1935 · External reference

Zur kenntnis der keratoconjunctivitis sicca IV: mikroskopische Untersuchungen über das Initialstadium der Drüsenveränderungen

10.1111/j.1755-3768.1938.tb04739.x · 1938 · External reference

Zur kenntnis der keratoconjunctivitis sicca V: Augenveränderungen nach Exstirpation der Tränendrüse. Behandlung

10.1111/j.1755-3768.1938.tb04740.x · 1938 · External reference

Zur kenntnis der keratoconjunctivitis sicca VI: das Siccasyndrom und ähnliche Zustände. Dacryo‐Sialo‐Adenopathia atrophicans

10.1111/j.1755-3768.1940.tb07967.x · 1940 · External reference

Sjögren's syndrome associated with lymphoblastoma and hypersplenism

1951 · External reference

A clinicopathologic study of Mikulicz's disease

1953 · External reference

Precipitating autoantibodies in Sjögren's disease

10.1016/s0140-6736(61)92430-8 · 1961 · External reference

Sjögren's syndrome. A clinical, pathological, and serological study of sixty‐two cases

10.1097/00005792-196505000-00001 · 1965 · External reference

Sjögren's syndrome

10.1016/0030-4220(66)90236-2 · 1966 · External reference

Zur kenntnis der keratoconjunctivitis sicca VII: Das Sicca‐Syndrom—Eine autoimmune Krankheit

10.1111/j.1755-3768.1968.tb05177.x · 1968 · External reference

Labial salivary gland biopsy in Sjogren's disease

10.1136/jcp.21.5.656 · 1968 · External reference

Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus

10.4049/jimmunol.102.1.117 · 1969 · External reference

Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus description of a cytoplasmic nonribosomal antigen

10.1002/art.1780170413 · 1974 · External reference

Zur kenntnis der keratoconjunctivitis sicca VIII. Uebersicht—Ätiologie

10.1111/j.1755-3768.1971.tb08678.x · 1971 · External reference

The histopathology of Sjögren's syndrome in labial salivary gland biopsies

10.1016/0030-4220(74)90417-4 · 1974 · External reference

The oral component of Sjögren's syndrome

10.1016/0030-4220(75)90108-5 · 1975 · External reference

The Copenhagen criteria for Sjögren's syndrome

10.1080/15027732.1986.12461371 · 1986 · External reference

Antibodies to cellular antigens in Sjögren's syndrome

10.1172/jci108007 · 1975 · External reference

Resolution of the identity of certain antigen‐antibody systems in systemic lupus erythematosus and Sjögren's syndrome: an interlaboratory collaboration

10.1002/art.1780220719 · 1979 · External reference

Connective‐tissue disease, antibodies to ribonucleoprotein, and congenital heart block

10.1056/nejm198307283090403 · 1983 · External reference

Labial salivary gland biopsy in Sjögren's syndrome

10.1002/art.1780270205 · 1984 · External reference

The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs

10.1073/pnas.81.7.1996 · 1984 · External reference

Sjögren's syndrome. Proposed criteria for classification

10.1002/art.1780290501 · 1986 · External reference

Preliminary diagnostic criteria for Sjögren's syndrome

10.1080/15027732.1986.12461372 · 1986 · External reference

A 52‐kD protein is a novel component of the SS‐A/Ro antigenic particle

10.1084/jem.167.5.1560 · 1988 · External reference

Salivary gland echography in primary and secondary Sjögren's syndrome

1992 · External reference

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European community

10.1002/art.1780360309 · 1993 · External reference

Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American‐European Consensus Group

10.1136/ard.61.6.554 · 2002 · External reference

UK Sjögren's Interest Group. Validation of the sicca symptoms inventory for clinical studies of Sjögren's syndrome

2003 · External reference

Measurement of fatigue and discomfort in primary Sjögren's syndrome using a new questionnaire tool

10.1093/rheumatology/keh170 · 2004 · External reference

Sjögren's syndrome disease damage index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients

10.1002/art.22658 · 2007 · External reference

Sjogren's Systemic Clinical Activity Index (SCAI) a systemic disease activity measure for use in clinical trials in primary Sjogren's syndrome

10.1093/rheumatology/kem280 · 2007 · External reference

EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

10.1136/ard.2009.110619 · 2010 · External reference

EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome

10.1136/ard.2010.143743 · 2011 · External reference

American College of Rheumatology classification criteria for Sjögren's syndrome: a data‐driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance Cohort

10.1002/acr.21591 · 2012 · External reference

Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies

10.1136/annrheumdis-2015-208504 · 2016 · External reference

Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome

10.1136/annrheumdis-2016-210448 · 2017 · External reference

2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: a consensus and data‐driven methodology involving three international patient cohorts

10.1002/art.39859 · 2017 · External reference

Salivary gland ultrasound abnormalities in primary Sjögren's syndrome: consensual US‐SG core items definition and reliability

10.1136/rmdopen-2016-000364 · 2017 · External reference

Video clip assessment of a salivary gland ultrasound scoring system in Sjögren's syndrome using consensual definitions: an OMERACT ultrasound working group reliability exercise

10.1136/annrheumdis-2019-215024 · 2019 · External reference

Composite of relevant endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measure

10.1016/s2665-9913(21)00122-3 · 2021 · External reference

Development of a new ultrasound scoring system to evaluate glandular inflammation in Sjögren's syndrome: an OMERACT reliability exercise

10.1093/rheumatology/keab876 · 2022 · External reference

Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome

10.1136/annrheumdis-2021-222054 · 2022 · External reference

The birthday of a new syndrome: IgG4‐related diseases constitute a clinical entity

10.1016/j.autrev.2010.05.003 · 2010 · External reference

Mikulicz's disease and Mikulicz's syndrome: analysis of the original case report of 1892 in the light of current knowledge identifies a MALT lymphoma

10.1016/j.tripleo.2005.01.016 · 2005 · External reference

Some new investigations concerning the sicca‐syndrome

10.1111/j.1755-3768.1961.tb00276.x · 1961 · External reference

Lacrimal and salivary precipitating antibodies in Sjögren's syndrome

10.1016/s0140-6736(58)91480-6 · 1958 · External reference

Differentiation and characterization of autoantibodies and their antigens in Sjögren's syndrome

10.1002/art.1780190214 · 1976 · External reference

Isolated anti‐Ro52 identifies a severe subset of Sjögren's syndrome patients

10.3389/fimmu.2023.1115548 · 2023 · External reference

Candidate autoantibodies for primary Sjögren's syndrome: where are they now?

2021 · External reference

How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project)

2018 · External reference

Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)

10.1136/annrheumdis-2013-204615 · 2015 · External reference

Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi‐ethnic cohort of patients

2019 · External reference

Early diagnosis of primary Sjögren's syndrome: EULAR‐SS task force clinical recommendations

10.1586/1744666x.2016.1109449 · 2016 · External reference

Performance of the 2016 ACR/EULAR SS classification criteria in patients with secondary Sjögren's syndrome

2020 · External reference

The SSB‐positive/SSA‐negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome

10.1136/annrheumdis-2014-206683 · 2015 · External reference

Isolated anti‐SS‐B (La) antibodies: rare occurrence and lack of diagnostic value

10.1136/rmdopen-2024-005212 · 2025 · External reference

Association of anticentromere antibodies with more severe exocrine glandular dysfunction in Sjögren's syndrome: analysis of the Sjögren's International Collaborative Clinical Alliance Cohort

10.1002/acr.22859 · 2016 · External reference

Sjögren's syndrome and systemic lupus erythematosus: links and risks

10.2147/oarrr.s167783 · 2019 · External reference

Clinical characteristics and prognostic value of Ro52/SSA antibodies in idiopathic inflammatory myopathies

10.1097/rhu.0000000000002015 · 2023 · External reference

Sjögren‐like syndrome, and chronic graft‐versus‐host disease

10.7326/0003-4819-87-6-707 · 1977 · External reference

Sjögren's syndrome‐like illness associated with the acquired immunodeficiency syndrome‐related complex

10.1016/s0046-8177(87)80223-x · 1987 · External reference

Hepatitis C virus infection mimicking primary Sjögren syndrome

10.1097/00005792-200101000-00001 · 2001 · External reference

The differential diagnosis of dry eyes, dry mouth, and parotidomegaly: a comprehensive review

10.1007/s12016-014-8431-1 · 2015 · External reference

Lessons from diseases mimicking Sjögren's syndrome

10.1007/s12016-007-8006-5 · 2007 · External reference

Sjögren's syndrome and lymphadenopathy unraveling the diagnosis of Lyme disease

10.5114/reum.2019.83242 · 2019 · External reference

Enlargement of salivary glands in bulimia

10.1017/s002221510012729x · 1994 · External reference

Immune checkpoint inhibitor‐induced sicca syndrome

10.1016/j.rdc.2024.02.004 · 2024 · External reference

Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants

10.1002/art.30381 · 2011 · External reference

Diagnostic value of labial minor salivary gland biopsy for Sjögren's syndrome: a systematic review

10.1016/j.autrev.2012.08.001 · 2013 · External reference

Natural history and predictors of progression to Sjögren's syndrome among participants of the Sjögren's International Collaborative Clinical Alliance Registry

10.1002/acr.23264 · 2018 · External reference

Diagnostic utility of a second minor salivary gland biopsy in patients with suspected Sjögren's syndrome: a retrospective cohort study

10.1016/j.jbspin.2022.105459 · 2023 · External reference

Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers

10.1002/art.10668 · 2002 · External reference

Increased diagnostic accuracy of the labial gland biopsy in primary Sjögren syndrome when multiple histopathological features are included

10.1002/art.42723 · 2024 · External reference

The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren's syndrome

10.1136/annrheumdis-2013-204634 · 2014 · External reference

A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome

10.1177/0961203314554251 · 2015 · External reference

Is minor salivary gland biopsy more than a diagnostic tool in primary Sjögren's syndrome? Association between clinical, histopathological, and molecular features: a retrospective study

10.1016/j.semarthrit.2014.05.015 · 2014 · External reference

Germinal centres in diagnostic labial gland biopsies of patients with primary Sjögren's syndrome are not predictive for parotid MALT lymphoma development

10.1136/annrheumdis-2017-211290 · 2017 · External reference

Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome

10.1136/ard.2010.144782 · 2011 · External reference

High‐grade salivary‐gland involvement, assessed by histology or ultrasonography, is associated with a poor response to a single rituximab course in primary Sjögren's syndrome: data from the TEARS Randomized Trial

10.1371/journal.pone.0162787 · 2016 · External reference

Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment

10.1136/annrheumdis-2015-208304 · 2016 · External reference

Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi‐center, follow‐up study

10.1186/ar4359 · 2013 · External reference

FcRL4+ B‐cells in salivary glands of primary Sjögren's syndrome patients

10.1016/j.jaut.2017.03.012 · 2017 · External reference

BAFF‐modulated repopulation of B lymphocytes in the blood and salivary glands of Rituximab‐treated patients with Sjögren's syndrome

10.1002/art.22603 · 2007 · External reference

Small‐molecule inhibitors and the salivary gland epithelium in Sjögren's syndrome

10.1080/13543784.2019.1631796 · 2019 · External reference

Diagnostic value of ultrasound evaluation of major salivary glands for Sjögren's syndrome based on the novel OMERACT scoring system

10.1016/j.ejrad.2023.110765 · 2023 · External reference

The impact of an ultrasound atlas for scoring salivary glands in primary Sjögren's syndrome: a pilot study

10.1007/s10067-023-06696-4 · 2023 · External reference

The diagnostic performance of salivary gland ultrasound elastography in Sjögren's syndrome and sicca symptoms: a systematic review and meta‐analysis

10.1007/s00330-023-10166-5 · 2023 · External reference

Primary Sjögren's syndrome: diagnostic and prognostic value of salivary gland ultrasonography using a simplified scoring system

10.1002/acr.22264 · 2014 · External reference

Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjögren's syndrome

10.1136/annrheumdis-2017-211250 · 2017 · External reference

Incorporation of salivary gland ultrasonography into the American College of Rheumatology/European League Against Rheumatism criteria for primary Sjögren's syndrome

10.1002/acr.24017 · 2020 · External reference

Diagnostic accuracy of salivary gland ultrasound in Sjögren's syndrome: a systematic review and meta‐analysis

10.1177/1759720x20973560 · 2020 · External reference

Ultrasonographic changes of major salivary glands in primary Sjögren's syndrome. Diagnostic value of a novel scoring system

10.1093/rheumatology/keh588 · 2005 · External reference

The development of malignant lymphoma in the course of Sjögren's syndrome

10.1016/0002-9343(64)90101-9 · 1964 · External reference

Increased risk of lymphoma in sicca syndrome

10.7326/0003-4819-89-6-888 · 1978 · External reference

Primary Sjögren's syndrome and malignancy risk: a systematic review and meta‐analysis

10.1136/annrheumdis-2013-203305 · 2014 · External reference

Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies

10.1093/rheumatology/keac205 · 2022 · External reference

Ectopic lymphoid neogenesis in rheumatic autoimmune diseases

10.1038/nrrheum.2016.217 · 2017 · External reference

Lymphomagenesis in Sjögren's syndrome: predictive biomarkers towards precision medicine

10.1016/j.autrev.2018.08.007 · 2019 · External reference

Prognostic markers of lymphoma development in primary Sjögren syndrome

10.1177/0961203319857132 · 2019 · External reference

Characterization and risk estimate of cancer in patients with primary Sjögren syndrome

10.1186/s13045-017-0464-5 · 2017 · External reference

Clinical picture, outcome and predictive factors of lymphoma in primary Sjögren's syndrome: results from a harmonized dataset (1981–2021)

10.1093/rheumatology/keab939 · 2022 · External reference

Mortality risk factors in primary Sjögren syndrome: a real‐world, retrospective, cohort study

10.1016/j.eclinm.2023.102062 · 2023 · External reference

Prediction of Sjögren's syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling

10.1002/art.39214 · 2015 · External reference

Anti‐SSA/SSB‐negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution

10.1016/j.autrev.2015.07.002 · 2015 · External reference

Phenotyping Sjögren's syndrome: towards a personalised management of the disease

2018 · External reference

Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome

10.1093/rheumatology/keh407 · 2005 · External reference

Sjögren's syndrome: the clinical spectrum of male patients

10.3390/jcm9082620 · 2020 · External reference

Symptom‐based stratification of patients with primary Sjögren's syndrome: multi‐dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials

10.1016/s2665-9913(19)30042-6 · 2019 · External reference

A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome

10.1038/s41467-021-23472-7 · 2021 · External reference

ChatGPT's Epoch in rheumatological diagnostics: a critical assessment in the context of Sjögren's syndrome

2023 · External reference

Development and verification of a combined diagnostic model for primary Sjögren's syndrome by integrated bioinformatics analysis and machine learning

10.1038/s41598-023-35864-4 · 2023 · External reference

New frontiers in precision medicine for Sjogren's syndrome

10.1080/1744666x.2021.1879641 · 2021 · External reference

Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sjögren's syndrome: a novel pathogenetic scenario?

2019 · External reference

Integrative analysis reveals a molecular stratification of systemic autoimmune diseases

10.1002/art.41610 · 2021 · External reference

Differential diagnosis of systemic lupus erythematosus and Sjögren's syndrome using machine learning and multi‐omics data

10.1016/j.compbiomed.2022.106373 · 2023 · External reference